This announcement is a separate document:
康弘药业：关于2023年股票增值权激励计划内幕信息知情人及激励对象买卖公司股票情况的自查报告
Kanghong Pharmaceutical: Self-inspection report on insider information on the 2023 Stock Value-added Rights Incentive Plan and the incentive target\'s stock trading situation
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.